XML 27 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:        
Net income $ 47,350 $ 262,405 $ 51,438  
Income from continuing operations before income taxes (6,905) 24,208 25,831  
Gain on sale of discontinued operations, net of income tax 11,957 283,025 9,393  
Income (loss) from continuing operations 42,298 (44,828) 16,214  
Adjustments to reconcile net income to net cash (used in) provided by operating activities:        
Depreciation expense 43,891 45,960 39,475  
Amortization of debt issuance costs 4,018 4,038 3,740  
Impairment expense 8,182 89,400 0  
Gain (Loss) on Disposition of Assets 24,218 0 0  
Loss on debt extinguishment 0 0 534  
Noncontrolling stockholder stock based compensation 16,345 9,451 10,519  
Provision for Other Losses (7,044) (62) (689)  
Deferred taxes (17,879) (19,800) 3,023  
Other 1,171 1,658 2,342  
Changes in operating assets and liabilities, net of acquisitions:        
Accounts receivable (117,742) (19,941) (43,420)  
Inventories (229,365) (65,492) (146,220)  
Other current and non-current assets 3,132 (1,945) (12,772)  
Accounts payable and accrued expenses 51,091 (72,903) (7,299)  
Net cash provided by (used in) operating activities - continuing operations (72,629) 15,107 (51,203)  
Net cash provided by operating activities - discontinued operations 4,993 62,973 22,910  
Net cash provided by (used in) operating activities (67,636) 78,080 (28,293)  
Net Cash Provided by (Used in) Investing Activities [Abstract]        
Acquisitions, net of cash acquired (517,856) 0 (569,028)  
Purchases of property and equipment (56,701) (55,016) (60,183)  
Proceeds from sale of businesses 74,719 500,305 9,393  
Other investing activities (4,296) (1,742) (1,102)  
Net cash provided by (used in) investing activities - continuing operations (504,134) 443,547 (620,920)  
Net cash provided by (used in) investing activities - discontinued operations 81,684 126,956 (5,803)  
Net cash provided by (used in) investing activities (422,450) 570,503 (626,723)  
Cash flows from financing activities:        
Proceeds from Issuance of Common Stock 7,707 74,259 83,851  
Proceeds from issuance of preferred stock 114,914 0 0  
Borrowings under credit facility 585,000 360,000 268,000  
Repayments under credit facility (475,000) (515,000) (113,000)  
Distributions paid - common shares (75,490) (71,967) (70,845)  
Distributions paid - preferred shares (25,458) (24,181) (24,181)  
Net proceeds provided by noncontrolling shareholders 41,947 15,599 1,312  
Distributions paid - Allocation Interests 48,941 26,475 0  
Purchase of noncontrolling interest 4,490 41,297 1,957  
Payments to Noncontrolling Interests 0 (11,745) (11,292)  
Debt issuance costs 0 0 (5,276)  
Other (4) (17) 10  
Net cash provided by (used in) financing activities 100,614 (260,163) 556,885  
Foreign currency impact on cash (1,278) 786 (1,331)  
Net increase (decrease) in cash and cash equivalents (390,750) 389,206 (99,462)  
Cash and cash equivalents — beginning of period (1) 450,477 61,271 160,733  
Cash and cash equivalents — end of period 59,727 450,477 61,271 $ 160,733
Cash from discontinued operations   3,800 8,500 $ 14,300
Payments for Repurchase of Common Stock (9,571) (9,339) 0  
Proceeds from Issuance of Other Long-term Debt 0 0 400,000  
Repayments of Other Long-term Debt (10,000) (10,000) (5,000)  
Proceeds from Minority Shareholders - Acquisitions 0 0 35,263  
Amortization expense 99,760 88,396 77,237  
Amortization of Acquisition Costs $ 5,295 $ 1,175 $ 6,113